ArticleACS pharmacology & translational science2025

Hit-to-Lead Studies of Pyrazinylpiperazines against Visceral Leishmaniasis: Pharmacokinetic Profile and

Thibault Joseph William Jacques Dit Lapierre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.